Zobrazeno 1 - 10 of 386 pro vyhledávání: '"H.B. Carter"'
1
Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance
Autor: Sasha C. Druskin, Jeffrey J. Tosoian, Mufaddal Mamawala, Christian P. Pavlovich, Lori J. Sokoll, Michael A. Gorin, Ashley E. Ross, Jonathan I. Epstein, Zeyad Schwen, H.B. Carter
Publikováno v: BJU International. 126:373-378
Objective To identify the value of combining the Prostate Health Index (PHI) and multiparametric magnetic resonance imaging (mpMRI), tools which have previously been shown to be independently predictive of prostate cancer (PCa) grade reclassification
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f6655db38dc1d6aec0019fc5b027af23
https://doi.org/10.1111/bju.15101
Zobrazit plný text záznamu
2
Germline mutations in PPFIBP2 are associated with lethal prostate cancer
Autor: Yishuo Wu, Siqun Lilly Zheng, William B. Isaacs, Julie L. Boyle, Charles M. Ewing, Bing Jian Feng, Ashley L. Kapron, Zhuqing Shi, H.B. Carter, Hongjie Yu, Rong Na, Sameep Shah, Jianfeng Xu, Patrick C. Walsh, Kathleen E. Wiley, Jun Luo, Brian T. Helfand, Kathleen A. Cooney
Publikováno v: The Prostate. 78:1222-1228
BACKGROUND Few genes have germline mutations which predispose men to more aggressive prostate cancer (PCa). This study evaluated the contribution of germline loss of function (LOF) variants in PPFIBP2 to risk of lethal PCa. METHODS A case-case study
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b6a1709fe5e9d009f4149e5ad211f35
https://doi.org/10.1002/pros.23697
Zobrazit plný text záznamu
3
Prostate Health Index density improves detection of clinically significant prostate cancer
Autor: Mufaddal Mamawala, Alan W. Partin, Lori J. Sokoll, Meera Chappidi, Sarah Joo, Ashley E. Ross, Jeffrey J. Tosoian, H.B. Carter, Darian Andreas, Patrick Mullane, Kamyar Ghabili, Sasha C. Druskin, Joseph Agostino
Publikováno v: BJU International. 120:793-798
Objectives To explore the utility of prostate health index (PHI) density for detection of clinically-significant prostate cancer (PCa) in a contemporary cohort of men presenting for diagnostic workup of PCa. Patients & Methods The study cohort includ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::485ff4bf9dac2d321604b2ddff37e4fe
https://doi.org/10.1111/bju.13762
Zobrazit plný text záznamu
4
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice
Autor: Jeffrey J. Tosoian, Patrick Mullane, Katarzyna J. Macura, H.B. Carter, Alan W. Partin, Meera Chappidi, Ashley E. Ross, Edward M. Schaeffer, Joseph Agostino, Kamyar Ghabili, Darian Andreas, Sasha C. Druskin, Sarah Joo, Lori J. Sokoll
Publikováno v: Prostate cancer and prostatic diseases
The Prostate Health Index (phi) outperforms PSA and other PSA derivatives for the diagnosis of prostate cancer (PCa). The impact of phi testing in the real-world clinical setting has not been previously assessed.In a single, large, academic center, p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e7cfabe09886a59ace0e3e091a3b7a
https://doi.org/10.1038/pcan.2016.72
Zobrazit plný text záznamu
6
A Bayesian hierarchical model for prediction of latent health states from multiple data sources with application to active surveillance of prostate cancer
Autor: Mufaddal Mamawala, Aaron Fisher, Kenneth J. Pienta, Scott L. Zeger, Rebecca Yates Coley, H.B. Carter
Publikováno v: Biometrics. 73:625-634
In this article, we present a Bayesian hierarchical model for predicting a latent health state from longitudinal clinical measurements. Model development is motivated by the need to integrate multiple sources of data to improve clinical decisions abo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c57f19eb8a45103225f2542c06c79f1c
https://doi.org/10.1111/biom.12577
Zobrazit plný text záznamu
9
Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
Autor: Hiten D. Patel, Debra J. Elliott, Lori J. Sokoll, Christian P. Pavlovich, Ashley E. Ross, Patricia Landis, Mufaddal Mamawala, H.B. Carter, Jeffrey J. Tosoian, Sacha Wolf, Jonathan I. Epstein
Publikováno v: Prostate cancer and prostatic diseases
To assess the utility of urinary prostate cancer antigen 3 (PCA3) as both a one-time and longitudinal measure in men on active surveillance (AS). The Johns Hopkins AS program monitors men with favorable-risk prostate cancer with serial PSA, digital r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77be74cd51a1f8a4b9b2b3596f40d590
https://pubmed.ncbi.nlm.nih.gov/28485411
Zobrazit plný text záznamu
10
Modeling grade progression in an active surveillance study
Autor: Alan W. Partin, Lurdes Y. T. Inoue, H.B. Carter, Bruce J. Trock, Ruth Etzioni
Publikováno v: Statistics in Medicine. 33:930-939
Prostate cancer grade, assessed with the Gleason score, describes how abnormal the tumor tissue and cells appear, and it is an important prognostic indicator of disease progression. Whether prostate tumors change grade is a question that has implicat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ec786bdc3cf5db7034ec9814ee9e27
https://doi.org/10.1002/sim.6003
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje